Literature DB >> 7747294

Salivary antibody detection in epidemiological surveys: a pilot study after a mass vaccination campaign against rubella in São Paulo, Brazil.

R S de Azevedo Neto1, A Richards, D J Nokes, A S Silveira, B J Cohen, S D Passos, V A de Souza, D W Brown, C S Pannuti, E Massad.   

Abstract

The sensitivity and specificity of salivary rubella antibody detection was investigated using samples collected from 301 children after a mass vaccination campaign in the state of São Paulo, Brazil. Saliva samples were collected by 2 different methods: directly dribbling into a container or using a commercial collecting device. Corresponding finger-prick blood samples were collected on filter paper. Rubella specific immunoglobulin G (IgG) was measured in saliva by antibody capture radioimmunoassay and in blood samples by indirect enzyme-linked immunosorbent assay. The detection of salivary rubella specific IgG showed good correlation with the detection of rubella antibody in the blood samples. For both collecting techniques the predictive value for a positive saliva test was > 99% compared with the results from the blood tests. However, the predictive value for a negative saliva test was only 58.3% for a dribbled sample, compared to 100% for saliva collected using the commercial device. Moreover, collecting saliva by dribbling from children less than 4 years old was difficult. The detection of rubella specific IgG in saliva collected using a commercial device proved to be sensitive and specific in this epidemiological study, encouraging its more widespread application as a means of surveillance after mass vaccination.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7747294     DOI: 10.1016/0035-9203(95)90680-0

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  8 in total

1.  Detection of specific antibodies in saliva during dengue infection.

Authors:  A J Cuzzubbo; D W Vaughn; A Nisalak; S Suntayakorn; J Aaskov; P L Devine
Journal:  J Clin Microbiol       Date:  1998-12       Impact factor: 5.948

2.  Diagnosis of dengue virus infection by detection of specific immunoglobulin M (IgM) and IgA antibodies in serum and saliva.

Authors:  Angel Balmaseda; María G Guzmán; Samantha Hammond; Guillermo Robleto; Carolina Flores; Yolanda Téllez; Elsa Videa; Saira Saborio; Leonel Pérez; Erick Sandoval; Yoryelin Rodriguez; Eva Harris
Journal:  Clin Diagn Lab Immunol       Date:  2003-03

3.  Diagnosis of parvovirus B19 infection by detection of specific immunoglobulin M antibody in saliva.

Authors:  R C Cubel; S A Oliveira; D W Brown; B J Cohen; J P Nascimento
Journal:  J Clin Microbiol       Date:  1996-01       Impact factor: 5.948

4.  Enzyme-linked immunosorbent assay using recombinant SAG1 antigen to detect Toxoplasma gondii-specific immunoglobulin G antibodies in human sera and saliva.

Authors:  Nouha Chahed Bel-Ochi; Aïda Bouratbine; Mohamed Mousli
Journal:  Clin Vaccine Immunol       Date:  2013-01-23

Review 5.  Application of Oral Fluid Assays in Support of Mumps, Rubella and Varicella Control Programs.

Authors:  Peter A C Maple
Journal:  Vaccines (Basel)       Date:  2015-12-09

6.  Use of traditional serological methods and oral fluids to assess immunogenicity in children aged 2-16 years after successive annual vaccinations with LAIV.

Authors:  Katja Hoschler; Sunil Maharjan; Heather Whitaker; Jo Southern; Blessing Okai; Janice Baldevarona; Paul J Turner; Nick J Andrews; Elizabeth Miller; Maria Zambon
Journal:  Vaccine       Date:  2020-02-15       Impact factor: 3.641

7.  Detection of rubella virus-specific immunoglobulin G in saliva by an amplification-based enzyme-linked immunosorbent assay using monoclonal antibody to fluorescein isothiocyanate.

Authors:  A J Vyse; D W Brown; B J Cohen; R Samuel; D J Nokes
Journal:  J Clin Microbiol       Date:  1999-02       Impact factor: 5.948

8.  Immunodiagnosis of dengue virus infection using saliva.

Authors:  Anita Chakravarti; Monika Matlani; Manisha Jain
Journal:  Curr Microbiol       Date:  2007-09-27       Impact factor: 2.343

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.